Advertisement
Organisation › Details
Senolytic Therapeutics (SenolyTx, ES)
At Senolytic Therapeutics, we develop novel classes of medicines that target and eliminate damaged (senescent) cells. Our mission is to advance our portfolio of therapies to clinical trials and improve the lives of those affected by diseases associated with aging. We have developed a unique technological portfolio which is based on drug therapies that eliminate senescent in age-related diseases. Senolytic Therapeutics is located in Boston (US) and Barcelona (Spain). We are a member of the Life Biosciences group. *
Start | 2019-01-09 existent | |
Group | Life Biosciences (Group) | |
Industry | BIOTECH | |
Industry 2 | LIFE SCIENCES | |
Person | Ramis, Marc (Senlytic Therapeutics 201901 CEO + Co-Founder) | |
Region | Barcelona | |
Country | Spain (España) | |
Street | 4–8 C/ Baldiri Reixac Barcelona Science Park | |
City | 08028 Barcelona | |
Tel | +34-607-046707 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
�About Section� taken from web site of organisation on 16.01. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Life Biosciences (Group)
- [1] Life Biosciences LLC. (1/15/19). "Press Release: Life Biosciences Announces Closing of $50 Million Series B Financing Round". Boston, MA....
- [2] Life Biosciences LLC. (1/9/19). "Press Release: Senolytic Therapeutics Kicks Off Q1 2019 with High-profile Speaking Events Featuring Co-founders Marc Ramis and Manuel Serrano". Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top